[USH2A外形13相关遗传视网膜变的基因疗法的进展]
1Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
|December 7, 2023
概括
USH2A基因变异导致视力丧失. 针对USH2A外因子13的治疗策略,包括反意义寡核酸和基因组编辑,显示出治疗阿舍尔综合征和视网膜色素炎的前景.
科学领域:
- 遗传学和眼科,专注于遗传性视网膜疾病.
背景情况:
- 在USH2A基因中的双性病原体变异导致阿舍尔综合征II型和非综合征性视网膜色素炎,导致渐进的光受体损失和失明.
- USH2A基因cDNA的大小 (15,606个基对) 对使用腺相关病毒载体的传统基因替代疗法提出了挑战.
结论:
- 准USH2A外因子13为阿舍尔综合征和视网膜色素炎提供了一个有前途的治疗途径.
- 基因疗法的进步对于应对像USH2A这样的大型基因所带来的挑战至关重要.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


